Cerebrolysin vs DSIP

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Cerebrolysin

Cerebrolysin is a mixture of low-molecular-weight neuropeptides and free amino acids derived from purified pig brain proteins. It is approved in many countries for stroke, traumatic brain injury, and dementia.

Full details →

DSIP

Delta Sleep-Inducing Peptide is a neuropeptide that promotes delta wave sleep, the deepest and most restorative phase of the sleep cycle.

Full details →

Side-by-Side Comparison

Aspect	Cerebrolysin	DSIP
Dose Range	2150 mg–4300 mg	100 mcg–300 mcg
Frequency	1x daily	1x daily
Cycle Length	1–2 weeks	1–6 weeks
Route	intramuscular	subcutaneous
Mechanism	Contains multiple neurotrophic factors that promote neuroplasticity, reduce neuronal apoptosis, and support synaptic function. Has both neurotrophic and neuroprotective properties.	Modulates sleep-wake cycles by affecting sleep spindles and delta rhythms. May also influence stress hormones and have analgesic properties.
Typical Dosage	Clinical dosing: 10-30ml IV daily for acute conditions. Research use: 5-10ml IM daily for cognitive enhancement. Treatment courses typically last 10-20 days.	Typical dosing: 100-300mcg administered 30 minutes before sleep. Some protocols use it cyclically.
Administration	Administered via intramuscular or intravenous injection. IV administration is typically used in clinical settings. IM can be used for research purposes.	Subcutaneous or intramuscular injection before bedtime. Some users report better results with cyclical use.
Side Effects	Generally well-tolerated. May cause dizziness, headache, sweating, or injection site reactions. Rare cases of agitation or confusion.	May cause grogginess upon waking, vivid dreams, or temporary headaches.
Best For	Recovery & Healing Cognitive Performance	Recovery & Healing Sleep Quality